Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMP | P19971 | 4/20 | 0.64 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | PRMT5 | O14744 | 2/20 | 0.45 |
| ▸ | WDR77 | Q9BQA1 | 2/20 | 0.45 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.45 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.44 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22367653 | 0.89 | TYMP (0.65) | TYMPHIF1ASLC29A1ADORA3 | |
| SCHEMBL532674 | 0.86 | TYMP (0.58) | TYMPHIF1ASLC29A1ADORA3ADORA1 | |
| SCHEMBL6905301 | 0.86 | TYMP (0.58) | TYMPHIF1ASLC29A1ADORA3ADORA1 | |
| SCHEMBL2239678 | 0.86 | TYMP (0.58) | TYMPHIF1ASLC29A1ADORA3ADORA1 | |
| SCHEMBL4826069 | 0.86 | TYMP (0.58) | TYMPHIF1ASLC29A1ADORA3ADORA1 | |
| SCHEMBL733367 | 0.86 | TYMP (0.47) | TYMPPRMT5WDR77ADORA1 | |
| SCHEMBL29720432 | 0.86 | TYMP (0.63) | TYMPSLC29A1ADORA3 | |
| SCHEMBL11040442 | 0.86 | TYMP (0.63) | TYMPSLC29A1ADORA3 | |
| SCHEMBL18486296 | 0.85 | TYMP (0.56) | TYMPSLC29A1ADORA3 | |
| SCHEMBL7065752 | 0.85 | TYMP (0.71) | TYMPHIF1AADORA3ADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8138330-B2 | Solid phase synthesis via deblocking immobilized nucleoside, then coupling acyl protected nucleoside phosphoramidite | SIGMA-ALDRICH CO. LLC (US) | 2012-03-20 | — | — | US | disclosed |